Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-27T21:21:55.506Z Has data issue: false hasContentIssue false
  • English
  • Français

Authors' reply

Published online by Cambridge University Press:  08 April 2014

P Kand  and
S Basu
P Kand
Affiliation:
Radiation Medicine Centre, Bhabha Atomic Research Centre, Parel, Mumbai, India
S Basu
Affiliation:
Radiation Medicine Centre, Bhabha Atomic Research Centre, Parel, Mumbai, India
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editors
Information
The Journal of Laryngology & Otology , Volume 128 , Issue 5 , May 2014 , pp. 482 - 483
Copyright
Copyright © JLO (1984) Limited 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Kand, P, Basu, S. Clinicoradiological characteristics of patients with differentiated thyroid carcinoma and renal metastasis: case series with follow up. J Laryngol Otol 2014;128:203–8Google Scholar
2Song, HJ, Xue, YL, Xu, YH, Qiu, ZL, Luo, QY. Rare metastases of differentiated thyroid carcinoma: pictorial review. Endocr Relat Cancer 2011;18:R165–74CrossRefGoogle ScholarPubMed
3Stokkel, MPM, Duchateau, CSJ, Dragoiescu, C. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging 2006;50:78–87Google Scholar
4Heston, TF, Wahl, RL. Molecular imaging in thyroid cancer. Cancer Imaging 2010;10:1–7Google Scholar
5Ong, SC, Ng, DCE, Sundram, FX. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans. Singapore Med J 2005;46:297–301Google ScholarPubMed
6Ma, C, Kuang, A, Xie, J, Ma, T. Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning. J Nucl Med 2005;46:1473–80Google Scholar